MedWatch

Novo Nordisk foundation gives billions back to Denmark to fund development

The Novo Nordisk Foundation’s role in Denmark is getting bigger and bigger, and in 2030, the foundation’s grants will reach a sum of DKK 10bn (USD 1.4bn). According to CEO Mads Krogsgaard Thomsen, public and private players must come together to shape society.

Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH

If the Novo Nordisk Foundation wasn’t sending billions of kroner back into its home country, Denmark would lose out on a bunch of opportunities, says the foundation’s CEO, Mads Krogsgaard Thomsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs